MRTP | Control | Difference | |
---|---|---|---|
Number of client years | 897.8 | 897.8 | |
Program delivery cost (incremental) | $987,926 | $0 | $987,926 |
Endpoint: ESKD treatment | |||
ESKD treatment years incurred | 27.7 | 64.5 | −36.8 |
ESKD treatment costs incurred | $3,120,350 | $7,265,796 | –$4,145,446 |
Total cost (program and ESKD costs) | $4,108,276 | $7,265,796 | –$3,157,521 |
Endpoint: dialysis start | |||
Relative risk for treatment versus control | 0.43 (0.19–0.96), p = 0.012 | ||
Reduction in risk of starting dialysis in the treatment versus control | 57 %, p = 0.03 | ||
Number of dialysis starts | 11 | 26 | −15 |
Lifetime ESKF treatment costs incurred | $3,853,332 | $9,107,875 | –$5,254,543 |
Total cost (program and lifetime ESKD costs) | $4,841,258 | $9,107,875 | –$4,266,618 |